The study-management committee designed the trial. The trial was endorsed by the Australian and New Zealand Intensive Care Culture Clinical Trials Group. The analysis protocol 9 was approved by the human research ethics committee at the Northern Sydney and Central Coast Area Health Services, the ethics committee in the University of Sydney, and by each participating organization. Written informed consent before randomization or delayed consent was obtained from each individual, legal surrogate, or institutional ethics committee.Kaiser Permanente has made crucial investments in people, data and technology, and facilities. As a total consequence of these efforts, the Kaiser Permanente currently is: Ranked initial in its region and 16th in the nation per National Committee for Quality Assurance Health Insurance Plan Rankings; Ranked by NCQA as #1 in the nation for Breast Cancers Screening, Childhood Immunizations Combo 4, Childhood Immunization Hepatitis A, Comprehensive Diabetes Care Nephropathy, and Comprehensive Diabetes care Eye Exams; Outpacing all local competitors on HEDIS Effectives of Treatment measures in the 90th %ile ; The highest performing business in its region on Consumer Assessment of Healthcare Suppliers and Systems study questions such as for example ‘Personal Doctor Ranking’ and ‘Specialist Rating’ Leading MAPMG can be Bernadette Loftus, MD, Associate Executive Director, The Permanente Medical Group.